Clinical Research Directory
Browse clinical research sites, groups, and studies.
Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).
Sponsor: Stanford University
Summary
This is a prospective non-randomized clinical trial to evaluate the feasibility of 3 fraction versus a standard 4 fraction high dose rate brachytherapy regimen in patients with locally advanced cervical cancer.
Official title: Brachytherapy Fractionation Individualized by Treatment Feasibility in Cervical Cancer: Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
41
Start Date
2025-06-03
Completion Date
2028-06
Last Updated
2025-06-15
Healthy Volunteers
No
Conditions
Interventions
3-Fraction HDR Brachytherapy
8 Gy per fraction for 3 fractions (total 24 Gy) for patients with locally advanced cervical cancer, based on individualized planning.
4-Fraction HDR Brachytherapy
7 Gy per fraction for 4 fractions (total 28 Gy) as the standard-of-care brachytherapy regimen.
Locations (1)
Stanford University
Palo Alto, California, United States